Latest News
Here you can find all the latest news from the MRC CTU at UCL.
Easy-to-take medicine better at suppressing HIV in children
Easy-to-take medicine better at suppressing HIV in children
Adding abiraterone to standard therapy helps men with high-risk localised prostate cancer to live longer
Adding abiraterone to standard therapy helps men with high-risk prostate cancer to live longer
Handbook on Monitoring of clinical trials launched
Handbook on Monitoring of clinical trials launched
UCL-TB to host WHO drug-resistant TB database
This platform will bring in data from multiple different sources, and make the new combined dataset available to researchers.
Quality of life better in men taking abiraterone rather than docetaxel for hormone-sensitive prostate cancer
This is according to results from an analysis of quality of life data from the STAMPEDE trial, which was published yesterday in the Journal of Clinical Oncology.